Clinical Evaluation and Utilization of Multiple Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2
Detection Principle
NucleicAcid-PCR based
Target
S, ORF1ab, RdRp regions
Testing Method Category
PCR_KIT
Testing Method
Abbott ID NOW COVID-19 (Abbott ID NOW), DiaSorin Molecular Simplexa COVID-19 Direct (DiaSorin Simplexa), and Roche cobas 6800 SARS-CoV-2 (Roche cobas)
Testing Method - Additional Info
clinical performance of 3 molecular assays
Reported Performance
positive percent agreement: 91% (Abbott), 100% (DiaSorin and Roche) ; negative percent agreement: 100%
Sample Size
184 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements